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P R E V I E W SA missing sugar prevents glucose entry:
A new twist on insulin secretion
The signaling pathway that regulates glucose-stimulated insulin secretion depends on glucose metabolism, which is itself
controlled by glucokinase. In a recent issue ofCell, Ohtsubo et al. (2005) show that altering N-glycosylation of the GLUT2 glu-
cose transporter prevents its anchoring and retention at the cell surface; this impairs glucose uptake and insulin secretion.Glucose homeostasis relies critically on
detection of variations in blood glucose
concentrations by pancreatic b cells,
and their subsequent timely release of
the appropriate amount of insulin. Glu-
cose sensing by pancreatic b cells re-
quires glucose uptake and metabolism
through the glycolytic pathway. Activa-
tion of the Krebs cycle and oxidative
phosphorylation generates ATP, and the
increase in the ATP to ADP ratio induces
plasmamembranedepolarizationbyclos-
ing an ATP-dependent K+ channel. This
leads to theopeningofvoltage-dependent
Ca2+ channels, and the entry of calcium
then triggers insulin granule exocytosis.
A recent study by Jamey Marth and col-
leagues (Ohtsubo et al., 2005) sheds
new light on the role of the glucose trans-
porter GLUT2 in regulating this process.
The rate-controlling step in glucose-
stimulated insulin secretion (GSIS) is the
phosphorylation of glucose by glucoki-
nase, which imposes the characteristic
sigmoidal glucose dose-dependent se-
cretion of insulin. Early biochemical evi-
dence for the critical role of glucokinase
(Matschinsky, 1996) was reinforced by
the finding that MODY2, an autosomal-
dominant form of early onset type 2 dia-
betes, was caused by mutation in the
glucokinase gene (Froguel et al., 1992).
Glucose uptake by b cells is catalyzed
by the low-affinity, high-capacity glucose
transporter GLUT2. In physiological con-
ditions, glucose uptake by this trans-
porter is in large excess over the rate
of phosphorylation by glucokinase, and
GLUT20s role in the glucose signaling
pathway is therefore only a permissive
one (Figure 1). However, GLUT2 expres-
sion is markedly downregulated in condi-
tions in which glucose-stimulated insulin
secretion is lost; this may occur through
dysregulation of the expression of tran-
scription factors such as Pdx-1 (Ahlgren
et al., 1998) or HNF-1a (Parrizas et al.,
2001). Although complete suppression
of GLUT2 gene expression suppresses
GSIS (Guillam et al., 1997), the causal re-CELL METABOLISM : JANUARY 2006lationship between the decreased ex-
pression of GLUT2 and the loss of GSIS
that are observed in rodent models of di-
abetes has not been clear.
In a recent study, Ohtsubo et al. inacti-
vated the gene for the Golgi N-acetylglu-
cosamine transferase 4a (GnT-4a, prod-
uct of the Mgat4a gene). The knockout
micewere hyperglycemicandhypoinsuli-
nemic and had impaired glucose toler-
ance, and insulin secretion as measured
using perifused islets showed sup-
pressed first-phase insulin secretion and
a second phase of reduced amplitude.
This secretion pattern is characteristic
of type 2 diabetes and also strikingly sim-
ilar to that of glut22/2 mouse islets
(Guillamet al., 1997). By analyzing the ex-
pression of GLUT2 in themgat42/2 islets,
Ohtsubo et al. showed that the trans-
porter synthesis rate was normal, but its
stability at the plasmamembrane was re-
duced leading to a reduction ofw50% in
total GLUT2 and to a reduction ofw90%
in surface-expressed transporter. This
was associated with a proportionate de-
crease in glucose transport rate. Further-
more, most of the GLUT2 was found in
early endosomes and lysosomes, indi-
cating an increased rate of endocytosis.
An earlier study of pancreatic islet
b cells from high-fat-fed mice had shown
an accumulation of GLUT2 in the cyto-
plasm and lower cell-surface expression
(Reimer and Ahren, 2002). Ohstubo et al.
evaluated the effects of high-fat feeding
on GnT-4a expression and found that its
mRNA expression was indeed reduced
by approximately 75% in high-fat-fed
mice, leading to reduction in GLUT2 ex-
pression and its associationwith early en-
dosomes and lysosomes. What then is
the link between GLUT2 N-linked glyco-
sylation and its cell-surface expression?
Ohtsubo et al., postulated that the N-
glycan structure was required to anchor
GLUT2 at the cell surface through an
interaction with a cell-surface lectin. In-
deed, in competition experiments, gly-
cans mimicking the structure of the sidechain missing in the knockout mice in-
ducedGLUT2 internalization in control is-
lets. Furthermore, the authors identified
galectin 9, also known as a urate trans-
porter (Lipkowitz et al., 2004), as the inter-
acting lectin, which could be efficiently
crosslinked with GLUT2 (Figure 1). Al-
though the N-glycans of other cell-
surface proteins, such as the insulin or in-
sulin-like growth factor receptors, were
also modified in the knockout mice, sur-
face expression of these species was
not reduced, indicating an element of
specificity in the control of GLUT2 cell-
surface expression.
These results are remarkable for multi-
ple reasons. First, the fact that anchoring
of GLUT2 at the b cell surface is depen-
dent on its interaction with galectin 9
was unexpected. The specificity of this
interaction forGLUT2andnot for theother
cell-surface proteins tested is surprising
and possibly suggests a hitherto unsus-
pected regulatory process controlling
insulin secretion. Suggestively, GLUT2
surface expression in hepatocytes is un-
affected in thesemgat4a knockout mice.
A final interesting observation is that
feeding mice a high-fat diet—which is
known to dysregulate insulin secretion—
markedly downregulates the expression
of this glycosyltransferase and is associ-
ated with a reduction of GLUT2 expres-
sion at the plasma membrane.
These findings nevertheless raise sev-
eral questions. An obvious one iswhether
the rate of glucose entry under these ex-
perimental conditions is low enough to
affect glucose access to glucokinase
and shift the rate-controlling step from
glucose phosphorylation to glucose up-
take. The authors demonstrate that the
rate of glucose transport can be de-
creased by up to 90% in the mutant
mice and that high-fat feeding reduces
total GLUT2 expression by w75% with
the transporter being mostly located in-
tracellularly. This extent of reduction in
GLUT2 cell-surface expression may in-
deed cause defective insulin secretion3
P R E V I E W SFigure 1. Glucose-stimulated insulin secretion requires glucose metabolism
The increase in ATP/ADP ratio is a key event linking rises in extracellular glucose concentrations to plasma membrane depolarization and Ca2+ influx, which causes
biphasic insulin secretion. In the normal physiological situation, glucose uptake allows unrestricted access of glucose to glucokinase, which catalyzes the rate-control-
ling step in the glucose signaling pathway. Ohtsubo et al. now show that preserving a high-glucose uptake rate requires the anchoring of GLUT2 to the plasma mem-
brane via interaction of its N-glycan with the cell-surface lectin galectin 9, also known as the urate transporter (UAT) (left panel). They further show that when the mgat4a
glycosyltransferase gene is inactivated, the structure of the GLUT2 N-glycan is modified so that it can no longer interact with galectin 9, provoking internalization of the
transporter into early endosomes and lysosomes (right panel). In this condition, glucose uptake rate is reduced tow10% of normal and becomes the rate-limiting step in
the signaling pathway, impairing normal glucose-stimulated insulin secretion. Remarkably, high-fat feeding of mice, which leads to dysregulated insulin secretion, also
leads to reduced mgat4a expression, modification of GLUT2 N-glycan structure, and GLUT2 internalization and may cause impaired insulin secretion.in response to glucose (Thorens et al.,
2000). Moreover, the possibility that
other insulin secretory response plasma
membrane proteins are also dysregu-
lated by modification of their N-glycan
cannot be completely excluded. Another
question is whether a similar mechanism
exists in other tissues where GLUT2 is
expressed, for example, the intestine,
kidney, or parts of the brain. GLUT2 ex-
pressing cells in the latter might be in-
volved in glucose sensing and regulation
of glucose or energy metabolism. The
mgat4a null mice become obese with
age and with high-fat feeding. The au-
thors attribute this to the defect in b cell
function, but it would be interesting to
evaluate whether defect in central glu-
cose sensing could also contribute to
this obesity phenotype.
The questions raised suggest that
some aspects of GLUT2 regulation in4b cells may have so far escaped our anal-
ysis. Finally, the causes of diabetes,
which has been linked variously to muta-
tions in the genes encoding metabolic
enzymes, transcription factors, signaling
molecules or ion channels, needs now
to the extended to N-glycan-modifying
enzymes. The authors correctly point to
studies showing that the human Mgat4a
andMgat4b genes are found at chromo-
somal positions 2q11-12 and 5q35, re-
spectively, which have been linked to
susceptibility to type2diabetes.Associa-
tion with diabetes of variants in this gene,
or in other glycosyltransferase genes
that could lead to GLUT2 N-glycans no
longer interacting with galectin 9, should
nowbe investigated.Altogether, thisstudy
shows the formidable, but at the same
time exciting, task researchers face to
understand the molecular control of glu-
cose homeostasis in health and its dereg-ulation inpathologicalconditions,andthat
far-reaching novel information can come
from totally unexpected horizons.
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the critical roles for ATP generation and
Insulin is synthesized in b cells of pancre-
atic islets and is secreted in response to
elevation in blood sugars. By stimulating
glucose uptake in peripheral tissues, in-
sulin promotes the storage of carbohy-
drates and regulates blood glucose lev-
els. Type 2 diabetes is characterized
by a persistently elevated blood glucose
level and is caused, in part, by impaired
insulin release from pancreatic b cells.
Thus, understanding the etiology of
type 2 diabetes as well as pharmaceuti-
cal approaches to treat the disorder re-
quires a detailed knowledge of how the
b cell senses and metabolizes glucose.
In this issue of Cell Metabolism, Freeman
and colleagues shed new light on the is-
sue by describing a role for diminished
mitochondrial Nnt activity as causal in
suppressed insulin release from pancre-
atic b cells.
The b cell uniquely couples changes in
cellular metabolism to electrical activity,
and thus insulin release (Figure 1). Under
conditions of low glucose, KATP channels
provide the dominant b cell membrane
conductance,maintaining themembrane
in a hyperpolarized state. However, in
the fed state, glucose enters the b cell
through glucose transporters (GLUTs)
and is rapidly metabolized, causing a
rise in the cytoplasmic [ATP]/[ADP] ratio.
This in turn causes closure of ATP-sensi-
tive K+ channels (KATP) at the cell surface,
leading to membrane depolarization
and opening of voltage-dependent Ca2+
channels (VDCCs). Calcium influx results
in a rise in intracellular calcium, which
triggers exocytosis of insulin vesicles
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pancreatic b cells is important for insulin re
subsequent closure of KATP channels for in
docked at the plasma membrane. This
model of excitation-secretion coupling
highlights the critical role of [ATP]/[ADP]
ratio in translating changes inmetabolism
to changes in electrical activity.
Mitochondrial metabolism accounts
for 95% of ATP production in the b cell
and factors that impairmitochondrial me-
tabolism are expected to decrease the
[ATP]/[ADP] ratio, prevent depolariza-
tion-driven Ca2+ influx, and thereby sup-
press insulin release. Previously, Toye
et al. (2005) mapped mutations in several
candidate genes that are postulated to
underlie the glucose intolerance and im-
paired b cell function that is characteristic
of inbred C57BL/6J mice. One of the mu-
tated genes is Nicotinamide nucleotide
transhydrogenase (Nnt), a nuclear-en-
coded mitochondrial protein involved in
detoxification of reactive oxygen species
(ROS) (Hoek and Rydstrom, 1988). Mito-
chondrial metabolism leads to the gener-
ation of ROS byproducts which, when el-
evated, can have deleterious effect on
mitochondrial ATP production. Detoxifi-
cation of ROS is necessary for normal mi-
tochondria function, and this process
requires a constant supply of NADPH,
generated by Nnt enzymatic activity.
Therefore, mutations in Nnt that diminish
its activity are expected to indirectly sup-
press insulin secretion, by uncoupling
proton-motive ATP production and thus
preventing the ATP-mediated closure of
KATP channels.
In the current study, Freeman et al.
(2006) provide compelling evidence for
diminished mitochondrial Nnt activity asThorens, B., Guillam, M.-T., Beermann, F., Bur-
celin, R., and Jaquet, M. (2000). J. Biol. Chem.
275, 23751–23758.
DOI 10.1016/j.cmet.2005.12.004s (ROS), byproducts of mitochondrial
In this issue of Cell Metabolism, Free-
lease. Their compelling data highlight
sulin secretion.
causal in suppressed insulin release from
pancreatic b cells. First, in MIN6 cells, an
insulin-secreting b cell line, knockdown
of endogenous Nnt activity is sufficient
to block the glucose-dependent rise in
intracellular Ca2+, the ‘‘trigger’’ for insulin
release. Second, the authors identify two
novel Nnt mutations in an ENU (ethylni-
trosourea)-mutagenized mouse archive.
Importantly, re-derivedhomozygousNnt-
mutated mice recapitulate the character-
istic features of C57BL/6J mice and are
glucose intolerant and hypoinsulinemic,
with reduced glucose-dependent insulin
release from isolated pancreatic islets.
Finally, the Nnt-mutated mice exhibit
reduced Nnt enzymatic activity and de-
creased ATP content in their pancreatic
b cells. Thus, decreased mitochondrial
ATP production in Nnt mutant mice can
account for the impaired glucose homeo-
stasis.
This comprehensive study makes a
compelling case for the proposed mech-
anism of Nnt-impaired secretion. How-
ever, there are additional pieces of infor-
mation that onemight like to see. There is
no direct demonstration that glucose-
dependent regulation of KATP activity is
actually altered, as has been demon-
strated in the case of reduced metabo-
lism in HNF1a-deficient mice (Dukes
et al., 1998). Other mechanisms, such
as reduced ATP sensitivity of KATP chan-
nels, could also cause such an effect.
The current work highlights a role of
Nnt in regulation of insulin release, by a
mechanism that may be common to pro-
teins which directly or indirectly reduce
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